ArticleInternational journal of endocrinology2026

Early Low-Dose Rituximab for Mild-to-Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety.

Ming Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.